Epidemiological associations between on and cardiovascular disease and diabetes

被引:89
|
作者
Basuli, Debargha [1 ]
Stevens, Richard G. [2 ]
Torti, Frank M. [1 ]
Torti, Suzy V. [1 ]
机构
[1] Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA
[2] Univ Connecticut, Ctr Hlth, Dept Community Med & Hlth Care, Div Epidemiol & Biostat, Farmington, CT 06030 USA
关键词
iron; cardiovascular disease; diabetes mellitus; metabolic syndrome; epidemiologic studies; NONALCOHOLIC FATTY LIVER; BODY IRON STORES; CORONARY-HEART-DISEASE; SERUM FERRITIN LEVELS; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; METABOLIC SYNDROME; ADIPOSE-TISSUE; RISK-FACTORS; INCREASED SUSCEPTIBILITY;
D O I
10.3389/fphar.2014.00117
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Disruptions in iron homeostasis are linked to a broad spectrum of chronic conditions including cardiovascular, malignant, metabolic, and neurodegenerative disease. Evidence supporting this contention derives from a variety of analytical approaches, ranging from molecular to population-based studies. This review focuses on key epidemiological studies that assess the relationship between body iron status and chronic diseases, with particular emphasis on atherosclerosis,metabolic syndrome and diabetes. Multiple surrogates have been used to measure body iron status, including serum ferritin, transferrin saturation, serum iron, and dietary iron intake. The lack of a uniform and standardized means of assessing body iron status has limited the precision of epidemiological associations. Intervention studies using depletion of iron to alter risk have been conducted. Genetic and molecular techniques have helped to explicate the biochemistry of iron metabolism at the molecular level. Plausible explanations for how iron contributes to the pathogenesis of these chronic diseases are beginning to be elucidated. Most evidence supports the hypothesis that excess iron contributes to chronic disease by fostering excess production of free radicals. Overall, epidemiological studies, reinforced by basic science experiments, provide a strong line of evidence supporting the association between iron and elevated risk of cardiovascular disease and diabetes. In this narrative review we attempt to condense the information from existing literature on this topic.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Diabetes and cardiovascular disease: Explaining the relationship
    Punthakee, Zubin
    Werstuck, Geoff H.
    Gerstein, Hertzel C.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2007, 8 (03) : 145 - 153
  • [22] Prevention of Diabetes and Cardiovascular Disease in Obesity
    La Sala, Lucia
    Pontiroli, Antonio E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 17
  • [23] The Burden of Cardiovascular Disease in Patients With Diabetes
    Hudspeth, Brooke
    AMERICAN JOURNAL OF MANAGED CARE, 2018, 24 (13): : S268 - S272
  • [24] Obesity and cardiovascular disease: From pathophysiology to risk stratification
    Marinou, Kyriakoula
    Tousoulis, Dimitris
    Antonopoulos, Alexios S.
    Stefanadi, Elli
    Stefanadis, Christodoulos
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 138 (01) : 3 - 8
  • [25] Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective
    Rhee, Eun-Jung
    ENDOCRINOLOGY AND METABOLISM, 2019, 34 (03) : 226 - 233
  • [26] Diabetes Mellitus, Arterial Stiffness and Cardiovascular Disease: Clinical Implications and the Influence of SGLT2i
    Lamacchia, Olga
    Sorrentino, Maria Rosaria
    CURRENT VASCULAR PHARMACOLOGY, 2021, 19 (02) : 233 - 240
  • [27] Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives
    Kreiner, Frederik Flindt
    Kraaijenhof, Jordan M.
    von Herrath, Matthias
    Hovingh, G. Kees Kornelis
    von Scholten, Bernt Johan
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (04) : 377 - 389
  • [28] Exposure to Perfluoroalkyl Chemicals and Cardiovascular Disease: Experimental and Epidemiological Evidence
    Meneguzzi, Alessandra
    Fava, Cristiano
    Castelli, Marco
    Minuz, Pietro
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [29] Link between the renin-angiotensin system and insulin resistance: Implications for cardiovascular disease
    Zhou, Ming-Sheng
    Schulman, Ivonne H.
    Zeng, Qiang
    VASCULAR MEDICINE, 2012, 17 (05) : 330 - 341
  • [30] Bi-directional analysis between fatty liver and cardiovascular disease risk factors
    Ma, Jiantao
    Hwang, Shih-Jen
    Pedley, Alison
    Massaro, Joseph M.
    Hoffmann, Udo
    Chung, Raymond T.
    Benjamin, Emelia J.
    Levy, Daniel
    Fox, Caroline S.
    Long, Michelle T.
    JOURNAL OF HEPATOLOGY, 2017, 66 (02) : 390 - 397